Search Login Register
Tamoxifen
Summary
8020
relevant articles (891 outcomes,
2078 trials/studies)
found for this Drug
Description:
One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.
Also Known As:
ICI-46,474; ICI-46474; ICI-47699; Nolvadex; Novaldex Show All >>
Key Diseases for which Tamoxifen is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
566 outcomes 1416 studies in 5122 results
-
Neoplasms (Cancer)
:
193 outcomes 304 studies in 1893 results
-
Carcinoma (Carcinomatosis)
:
33 outcomes 99 studies in 595 results
-
Neoplasm Metastasis (Metastasis)
:
31 outcomes 27 studies in 227 results
-
Endometrial Neoplasms (Endometrial Cancer)
:
26 outcomes 103 studies in 633 results
Show All >>
Drugs Related to Tamoxifen
-
Estrogens (Estrogen)
-
Hormones
-
anastrozole (Arimidex)
-
letrozole (Femara)
-
Aromatase Inhibitors
-
Estrogen Receptor Modulators (Antiestrogen)
-
exemestane (Aromasin)
-
Raloxifene (Evista)
-
Selective Estrogen Receptor Modulators (SERM)
-
Aromatase (CYP19)
Show All >>
Therapies Related to Tamoxifen
-
Drug Therapy (Chemotherapy)
-
Chemoprevention
-
Segmental Mastectomy (Lumpectomy)
-
Ovariectomy (Oophorectomy)
-
Mastectomy (Mammectomy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.